88 related articles for article (PubMed ID: 35537905)
1. Salvage partial gland ablation for recurrent prostate cancer following primary partial gland ablation: Functional and oncological outcomes.
Qaoud Y; Herrera-Caceres JO; Bass R; Berjaoui MB; Tiwari R; Kenk M; Lajkosz K; Finelli A; Perlis N; Klotz L; Fleshner N
Urol Oncol; 2022 Jul; 40(7):343.e1-343.e6. PubMed ID: 35537905
[TBL] [Abstract][Full Text] [Related]
2. Oncological and Functional Outcomes for Men Undergoing Salvage Whole-gland Cryoablation for Radiation-resistant Prostate Cancer.
Tan WP; Kotamarti S; Ayala A; Mahle R; Chen E; Arcot R; Chang A; Michael Z; Seguier D; Polascik TJ
Eur Urol Oncol; 2023 Jun; 6(3):289-294. PubMed ID: 36890104
[TBL] [Abstract][Full Text] [Related]
3. Median 4-year outcomes of salvage irreversible electroporation for localized radio-recurrent prostate cancer.
Geboers B; Scheltema MJ; Blazevski A; Katelaris A; Doan P; Ali I; Agrawal S; Barreto D; Matthews J; Haynes AM; Delprado W; Shnier R; Thompson JE; Stricker PD
BJU Int; 2023 Jun; 131 Suppl 4():14-22. PubMed ID: 36594205
[TBL] [Abstract][Full Text] [Related]
4. Partial gland ablation with high intensity focal ultrasound impact on genito-urinary function and quality of life: our initial experience.
Fugaru I; Bouhadana D; Marcq G; Moryousef J; Rompré-Brodeur A; Meng A; Loutochin O; Loutochin G; Anidjar M; Bladou F; Sanchez-Salas R
Can J Urol; 2024 Feb; 31(1):11784-11792. PubMed ID: 38401258
[TBL] [Abstract][Full Text] [Related]
5. Survival and quality of life outcomes of high-intensity focused ultrasound treatment of localized prostate cancer.
Royce PL; Ooi JJY; Sothilingam S; Yao HH
Prostate Int; 2020 Jun; 8(2):85-90. PubMed ID: 32647645
[TBL] [Abstract][Full Text] [Related]
6. Partial gland ablation using high-intensity focused ultrasound versus robot-assisted radical prostatectomy: a propensity score-matched study.
Jung G; Kim JK; Oh JJ; Lee S; Byun SS; Hong SK; Lee H
Prostate Int; 2023 Sep; 11(3):134-138. PubMed ID: 37745903
[TBL] [Abstract][Full Text] [Related]
7. Focal therapy with high-intensity focused ultrasound for prostate cancer: 3-year outcomes from a prospective trial.
Kaufmann B; Raess E; Schmid FA; Bieri U; Scherer TP; Elleisy M; Donati OF; Rupp NJ; Moch H; Gorin MA; Mortezavi A; Eberli D
BJU Int; 2024 Apr; 133(4):413-424. PubMed ID: 37897088
[TBL] [Abstract][Full Text] [Related]
8. Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement.
Deivasigamani S; Kotamarti S; Rastinehad AR; Salas RS; de la Rosette JJMCH; Lepor H; Pinto P; Ahmed HU; Gill I; Klotz L; Taneja SS; Emberton M; Lawrentschuk N; Wysock J; Feller JF; Crouzet S; Kumar M P; Seguier D; Adams ES; Michael Z; Abreu A; Jack Tay K; Ward JF; Shinohara K; Katz AE; Villers A; Chin JL; Stricker PD; Baco E; Macek P; Ahmad AE; Chiu PKF; Crawford ED; Rogers CG; Futterer JJ; Rais-Bahrami S; Robertson CN; Hadaschik B; Marra G; Valerio M; Chong KT; Kasivisvanathan V; Tan WP; Lomas D; Walz J; Guimaraes GC; Mertziotis NI; Becher E; Finelli A; Kasraeian A; Lebastchi AH; Vora A; Rosen MA; Bakir B; Arcot R; Yee S; Netsch C; Meng X; de Reijke TM; Tan YG; Regusci S; Benjamin TGR; Olivares R; Noureldin M; Bianco FJ; Sivaraman A; Kim FJ; Given RW; Dason S; Sheetz TJ; Shoji S; Schulman A; Royce P; Shah TT; Scionti S; Salomon G; Laguna P; Tourinho-Barbosa R; Aminsharifi A; Cathelineau X; Gontero P; Stabile A; Grummet J; Ledbetter L; Graton M; Stephen Jones J; Polascik TJ;
Eur Urol; 2023 Dec; 84(6):547-560. PubMed ID: 37419773
[TBL] [Abstract][Full Text] [Related]
9. Comparison of salvage radical prostatectomy vs. salvage ablation therapy for biopsy-proven radio-recurrent localized prostate cancer.
McPherson V; Nair SM; Tin AL; Dewar M; Siddiqui K; Sjoberg DD; Vickers AJ; Eastham J; Chin JL
Can Urol Assoc J; 2024 Feb; 18(2):41-46. PubMed ID: 37931280
[TBL] [Abstract][Full Text] [Related]
10. Recurrent Gleason Score 6 Prostate Cancer After Radiotherapy or Ablation: Should We Observe Them All? Results from a Large Multicenter Salvage Radical Prostatectomy Consortium.
Marra G; Calleris G; Conte F; Benfant N; Rajwa P; Ahmed M; Abreu A; Cacciamani G; Smith JA; Joniau S; Rodriguez-Sanchez L; Sanchez-Salas R; Cathcart P; Gill I; Karnes RJ; Tilki D; Shariat SF; Touijer K; Gontero P
Eur Urol Focus; 2023 Sep; ():. PubMed ID: 37704503
[TBL] [Abstract][Full Text] [Related]
11. Patient-reported functional outcomes and oncological control after primary focal cryotherapy for clinically significant prostate cancer: A Phase II mandatory biopsy-monitored study.
Tan YG; Law YM; Ngo NT; Khor LY; Tan PH; Ong EHW; Yuen JSP; Ho HSS; Tuan JKL; Kanesvaran R; Gupta RT; Rozen S; Chua MLK; Polascik TJ; Tay KJ
Prostate; 2023 Jun; 83(8):781-791. PubMed ID: 36895163
[TBL] [Abstract][Full Text] [Related]
12. Robot Partial Prostatectomy for Anterior Cancer: Long-term Functional and Oncological Outcomes at 7 Years.
Villers A; Seguier D; Puech P; Haber GP; Desai MM; Crouzet S; Leroy X; Labreuche J; Gill IS; Olivier J
Eur Urol Open Sci; 2023 Sep; 55():11-14. PubMed ID: 37521072
[TBL] [Abstract][Full Text] [Related]
13. Prostate gland lengths and iceball dimensions predict micturition functional outcome following salvage prostate cryotherapy in men with radiation recurrent prostate cancer.
Ahmad I; Kalna G; Ismail M; Birrell F; Asterling S; McCartney E; Greene D; Davies J; Leung HY
PLoS One; 2013; 8(8):e69243. PubMed ID: 23950886
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life following salvage radical prostatectomy for recurrent prostate cancer after radiotherapy or focal therapy.
Rodler S; Danninger D; Eismann L; Kazmierczak PM; Jokisch F; Li M; Becker A; Kretschmer A; Stief C; Westhofen T
World J Urol; 2024 Apr; 42(1):242. PubMed ID: 38635030
[TBL] [Abstract][Full Text] [Related]
15. Salvage high-intensity focused ultrasound (S-HIFU) for recurrence after primary radiotherapy of prostate cancer.
Long Depaquit T; Campagna J; Bastide C; Baboudjian M; Corral R; Uleri A; Toledano H
Fr J Urol; 2024 Mar; 34(5):102633. PubMed ID: 38547931
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Outcomes Following Focal Ablative Therapy for Treatment of Localized Clinically Significant Prostate Cancer in Patients >70 Years: A Multi-institute, Multi-energy 15-Year Experience.
Habashy D; Reddy D; Peters M; Shah TT; van Son M; van Rossum PSN; Tanaka MB; Cullen E; Engle R; McCracken S; Greene D; Hindley RG; Emara A; Nigam R; Orczyk C; Shergill I; Persad R; Virdi J; Moore CM; Arya M; Winkler M; Emberton M; Ahmed HU; Dudderidge T
J Urol; 2023 Jul; 210(1):108-116. PubMed ID: 37014172
[TBL] [Abstract][Full Text] [Related]
17. Follow-Up of Men Who Have Undergone Focal Therapy for Prostate Cancer with HIFU-A Real-World Experience.
Mala KS; Plage H; Mödl L; Hofbauer S; Friedersdorff F; Schostak M; Miller K; Schlomm T; Cash H
J Clin Med; 2023 Nov; 12(22):. PubMed ID: 38002699
[TBL] [Abstract][Full Text] [Related]
18. High-intensity focused ultrasound with visually directed power adjustment for focal treatment of localized prostate cancer: systematic review and meta-analysis.
Peretsman SJ; Emberton M; Fleshner N; Shoji S; Bahler CD; Miller LE
World J Urol; 2024 Mar; 42(1):175. PubMed ID: 38507093
[TBL] [Abstract][Full Text] [Related]
19. External validation of a risk model predicting failure of salvage focal ablation for prostate cancer.
Light A; Peters M; Reddy D; Kanthabalan A; Otieno M; Pavlou M; Omar R; Adeleke S; Giganti F; Brew-Graves C; Williams NR; Emara A; Haroon A; Latifoltojar A; Sidhu H; Freeman A; Orczyk C; Nikapota A; Dudderidge T; Hindley RG; Virdi J; Arya M; Payne H; Mitra AV; Bomanji J; Winkler M; Horan G; Moore C; Emberton M; Punwani S; Ahmed HU; Shah TT
BJU Int; 2023 Nov; 132(5):520-530. PubMed ID: 37385981
[TBL] [Abstract][Full Text] [Related]
20. High-Intensity Focused Ultrasound (Sonablate
Tsai MY; Lin CT; Chiang PH; Chiang PH; Chiang PC
Ann Surg Oncol; 2023 Dec; 30(13):8764-8769. PubMed ID: 37697133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
